Concert Pharmaceuticals, Inc

(NASDAQ:CNCE)

Latest On Concert Pharmaceuticals, Inc (CNCE):

Date/Time Type Description Signal Details
2023-02-17 01:47 ESTNewsConcert Pharmaceuticals: Negative Spread But Interesting CVRN/A
2023-02-15 23:02 ESTNewsConcert retains breakthrough status for hair loss therapy despite rival entryN/A
2023-01-19 17:23 ESTNewsConcert Pharmaceuticals rises on Sun Pharma's acquisition announcementN/A
2022-11-07 17:02 ESTNewsConcert Pharma GAAP EPS of -$0.58 beats by $0.01, revenue of $0.08M in-lineN/A
2022-11-07 17:02 ESTNewsConcert Pharmaceuticals, Inc. (CNCE) Q3 2022 Earnings Call TranscriptN/A
2022-11-07 17:02 ESTNewsConcert Pharma falls 13% after third quarter resultsN/A
2022-11-04 17:58 ESTNewsConcert Pharma Q3 2022 Earnings PreviewN/A
2022-08-09 00:34 ESTNewsCinCor Pharma hits 52-week high on data for antihypertensive agentN/A
2022-08-06 23:02 ESTNewsConcert Pharmaceuticals, Inc. (CNCE) CEO Roger Tung on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-04 09:26 ESTNewsConcert Pharma GAAP EPS of -$0.59 beats by $0.26, revenue of $0.02M misses by $0.06MN/A
2022-08-01 09:02 ESTNewsConcert says second late-stage study for hair loss therapy reached main goalN/A
2022-06-16 00:13 ESTNewsConcert Pharmaceuticals: A Balanced Risk/RewardN/A
2022-06-06 18:51 ESTNewsConcert Pharmaceuticals raises $66.4M through share offering and warrant exerciseN/A
2022-06-03 20:33 ESTNewsConcert Pharmaceuticals: A Speculative Buy For Their Alopecia Areata DrugN/A
2022-06-02 23:43 ESTNewsConcert Pharmaceuticals prices 10M stock offeringN/A
2022-06-01 13:00 ESTNewsConcert Pharma slides on 10M common stock offeringN/A
2022-05-23 16:46 ESTNewsConcert's CTP-543 helps hair regrowth in alopecia areata patients, meets trial's main goalN/A
2022-05-12 15:35 ESTNewsConcert Pharma surges as U.S. patent office upholds key patentN/A
2022-05-07 18:43 ESTNewsConcert Pharmaceuticals, Inc. (CNCE) CEO Roger Tung on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-06 01:20 ESTNewsConcert Pharma GAAP EPS of -$1.03N/A
2022-05-05 01:34 ESTNewsConcert Pharma Q1 2022 Earnings PreviewN/A
2022-03-04 03:12 ESTNewsConcert Pharmaceuticals, Inc. (CNCE) CEO Roger Tung on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-04 03:12 ESTNewsConcert Pharmaceuticals, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-03-03 09:41 ESTNewsConcert Pharma GAAP EPS of -$1.01 misses by $0.24, revenue of $0.01M in-lineN/A
2022-01-04 11:05 ESTNewsConcert Pharmaceuticals completes enrollment in phase 3 study of hair loss disorder drugN/A
2021-11-10 05:22 ESTNewsConcert Pharma EPS beats by $0.03, beats on revenueN/A
2021-11-10 05:21 ESTNewsConcert Pharmaceuticals, Inc. (CNCE) CEO Roger Tung on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-09 06:17 ESTNewsConcert Pharma Q3 2021 Earnings PreviewN/A
2021-11-05 03:36 ESTNewsConcert Pharmaceuticals signs agreement to raise $65M financingN/A
2021-10-25 15:28 ESTNewsConcert completes enrollment in late-stage CTP-543 alopecia areata trialN/A
2021-08-08 10:19 ESTNewsConcert Pharmaceuticals, Inc. (CNCE) CEO Roger Tung on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-06 00:37 ESTNewsConcert Pharma EPS beats by $0.58, beats on revenueN/A
2021-07-21 02:13 ESTNewsConcert Pharma on go with late-stage study of CTP-543 in alopecia areataN/A
2021-05-04 17:12 ESTNewsConcert Pharma EPS beats by $0.02N/A
2021-05-04 17:10 ESTNewsConcert Pharmaceuticals, Inc. (CNCE) CEO Roger Tung on Q1 2021 Results - Earnings Call TranscriptN/A
2021-02-28 03:41 ESTNewsConcert Pharmaceuticals, Inc. (CNCE) CEO Roger Tung on Q4 2020 Results - Earnings Call TranscriptN/A
2021-02-26 15:20 ESTFinancialsCompany financials have been released.Neutral
2021-02-26 07:23 ESTEarnings EstimateAn EPS average of -$2.34 is estimated for the 2022 year.Sell
2021-02-26 07:23 ESTEarnings EstimateAn EPS average of -$0.81 is estimated for the quarter ending on June 30, 2021.Sell
2021-02-25 22:48 ESTNewsConcert Pharma EPS beats by $0.09N/A
2021-02-12 16:38 ESTNewsConcert Pharmaceuticals Is Unlikely To Grab A Large Piece Of The Alopecia Areata Drug MarketN/A
2021-02-03 07:22 ESTAnalyst RatingThe Analyst Target Price has decreased from $18.67 to $15.Neutral
2021-02-02 11:26 ESTAnalyst RatingThe Analyst Target Price has decreased from $24 to $18.67.Neutral
2021-02-01 11:37 ESTNewsConcert Pharma fails in mid-stage study for CTP-692 SchizophreniaN/A
2020-12-17 11:35 ESTAnalyst RatingThe Analyst Target Price has increased from $23.8 to $24.Buy
2020-12-13 03:37 ESTFinancialsCompany financials have been released.Neutral
2020-11-25 11:39 ESTAnalyst RatingThe Analyst Target Price has increased from $23.5 to $23.8.Buy
2020-11-08 04:21 ESTNewsConcert Pharmaceuticals, Inc. (CNCE) CEO Roger Tung on Q3 2020 Results - Earnings Call TranscriptN/A
2020-11-07 15:26 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 03:30 ESTFinancialsCompany financials have been released.Neutral

About Concert Pharmaceuticals, Inc (CNCE):

Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. Its lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. Concert Pharmaceuticals has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologies; and Processa Pharmaceuticals. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

CNCE Quotes by TradingView

See Advanced Chart

General

  • Name Concert Pharmaceuticals, Inc
  • Symbol CNCE
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 71
  • Fiscal Year EndDecember
  • IPO Date2014-02-13
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.concertpharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 25.15
  • Price/Book (Most Recent Quarter) 1.56
  • Enterprise Value Revenue 11.26
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.88
  • Next Year EPS Estimate -$2.75
  • Next Quarter EPS Estimate -$0.82
  • Operating Margin -919%
  • Return on Assets -31%
  • Return on Equity -64%
  • Revenue 7.9 million
  • Earnings Per Share -$3.35
  • Revenue Per Share $0.25
  • Gross Profit -53722000
  • Quarterly Earnings Growth -46.2%
View More

Highlights

  • Market Capitalization 196.26 million
  • EBITDA -75635000
  • Analyst Target Price $15
  • Book Value Per Share $4.12
View More

Share Statistics

  • Shares Outstanding 32.17 million
  • Shares Float 24.88 million
  • % Held by Insiders 1025%
  • % Held by Institutions 70.92%
  • Shares Short 698720
  • Shares Short Prior Month 585095
  • Short Ratio 0.84
  • Short % of Float 2%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • Beta 0.64
  • 52 Week High $13.44
  • 52 Week Low $5.56
  • 50 Day Moving Average 7.13
  • 200 Day Moving Average 10.12
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Concert Pharmaceuticals, Inc (CNCE) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Concert Pharmaceuticals, Inc (CNCE) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$7000-$0.69-$0.7811.08%
2020-09-302020-11-05$1.5 million-$0.60-$0.7520%
2020-06-302020-08-06$N/A-$0.41-$0.7041.6%
2020-03-312020-04-30$N/A-$0.70-$0.778.79%
2019-12-312020-02-27$13000-$0.86-$0.79-9.46%
2019-09-302019-11-07$10000-$0.72-$0.8414.46%
2019-06-302019-08-01$49000-$0.78-$0.9114.27%
2019-03-312019-05-02$1.01 million-$0.93-$0.65-42.97%
2018-12-312019-02-28$13000-$0.89-$0.74-20.12%
2018-09-302018-11-01$11000-$0.74-$0.62-18.44%
2018-06-302018-08-02$2000-$0.57-$0.628.52%
2018-03-312018-05-03$10.48 million-$0.19-$0.5867.41%
2017-12-312018-03-01$12000-$0.26-$0.6056.9%
2017-09-302017-11-09$143.84 million$5.44$5.61-3.08%
2017-06-302017-08-08$15000-$0.58-$0.6611.97%
2017-03-312017-05-02$20000-$0.60-$0.59-1.69%
2016-12-312017-03-06$21000-$0.54-$0.6111.82%
2016-09-302016-11-08$26000-$0.51-$0.6318.89%
2016-06-302016-08-09$71000-$0.60-$0.635.06%
2016-03-312016-05-05$56000-$0.63-$0.45-38.8%
2015-12-312016-03-01$10.31 million$0.03-$0.09134.01%
2015-09-302015-11-05$1.71 million-$0.39-$0.31-25.81%
2015-06-302015-08-05$53.41 million$1.80-$0.46491.3%
2015-03-312015-05-08$1.31 million-$0.48-$0.44-9.09%
2014-12-312015-02-27$1.31 million-$0.36-$0.5938.98%
2014-09-302014-11-12$4.42 million-$0.43-$0.4912.24%
2014-06-302014-08-12$1.24 million-$0.45-$0.42-7.14%
2014-03-312014-05-14$1.61 million-$0.76-$0.760%
2013-12-312014-03-31$1.41 million-$4.64-$0.25-1756%

Concert Pharmaceuticals, Inc (CNCE) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Concert Pharmaceuticals, Inc (CNCE) Chart:

Concert Pharmaceuticals, Inc (CNCE) News:

Below you will find a list of latest news for Concert Pharmaceuticals, Inc (CNCE) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Concert Pharmaceuticals, Inc (CNCE) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest CNCE Trades:

Date Shares Price
Jun 13, 2022 7:58 PM EST100$4.155
Jun 13, 2022 7:58 PM EST90$4.155
Jun 13, 2022 7:59 PM EST5$4.155
Jun 13, 2022 7:59 PM EST94$4.15
Jun 13, 2022 7:59 PM EST34$4.16

Concert Pharmaceuticals, Inc (CNCE) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919120038683/0001209191-20-038683-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1367920/000021545719003165/0000215457-19-003165-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1367920/000083423720004765/0000834237-20-004765-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1367920/000083423720009079/0000834237-20-009079-index.htm
2018-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000089924318016208/0000899243-18-016208-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000089924318017069/0000899243-18-017069-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000089924318017070/0000899243-18-017070-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000089924318017073/0000899243-18-017073-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000089924318017074/0000899243-18-017074-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000089924318017077/0000899243-18-017077-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000089924318017079/0000899243-18-017079-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000089924318017080/0000899243-18-017080-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000089924318017081/0000899243-18-017081-index.htm
2019-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1367920/000092189519000247/0000921895-19-000247-index.htm
2019-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1367920/000092189519000248/0000921895-19-000248-index.htm
2019-04-02SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1367920/000092189519000972/0000921895-19-000972-index.htm
2019-04-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000092189519000975/0000921895-19-000975-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000092189519001804/0000921895-19-001804-index.htm
2019-07-03SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1367920/000092189519001963/0000921895-19-001963-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1367920/000092189520000540/0000921895-20-000540-index.htm
2019-01-30SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1367920/000104188519000010/0001041885-19-000010-index.htm
2020-01-23SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1367920/000104188520000003/0001041885-20-000003-index.htm
2020-02-06SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1367920/000117891320000299/0001178913-20-000299-index.htm
2018-11-23SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1367920/000119312518333094/0001193125-18-333094-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1367920/000119312519040926/0001193125-19-040926-index.htm
2020-01-28424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1367920/000119312520015952/0001193125-20-015952-index.htm
2020-01-28424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1367920/000119312520016954/0001193125-20-016954-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1367920/000119312520038356/0001193125-20-038356-index.htm
2020-11-05S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1367920/000119312520286213/0001193125-20-286213-index.htm
2018-04-134/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919118024843/0001209191-18-024843-index.htm
2018-04-134/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919118024845/0001209191-18-024845-index.htm
2018-04-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919118025549/0001209191-18-025549-index.htm
2018-07-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919118042304/0001209191-18-042304-index.htm
2018-11-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919118058781/0001209191-18-058781-index.htm
2018-11-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919118058782/0001209191-18-058782-index.htm
2018-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919118059254/0001209191-18-059254-index.htm
2018-11-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919118060364/0001209191-18-060364-index.htm
2019-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919119002754/0001209191-19-002754-index.htm
2019-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919119002756/0001209191-19-002756-index.htm
2019-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919119002757/0001209191-19-002757-index.htm
2019-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919119002759/0001209191-19-002759-index.htm
2019-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919119002762/0001209191-19-002762-index.htm
2019-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919119008083/0001209191-19-008083-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919119022405/0001209191-19-022405-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919119022410/0001209191-19-022410-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919119022413/0001209191-19-022413-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919119022418/0001209191-19-022418-index.htm
2019-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919119024246/0001209191-19-024246-index.htm
2019-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919119025761/0001209191-19-025761-index.htm
2019-05-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919119028279/0001209191-19-028279-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919119037560/0001209191-19-037560-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919119037561/0001209191-19-037561-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919119037562/0001209191-19-037562-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919119037563/0001209191-19-037563-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919119037564/0001209191-19-037564-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919119037565/0001209191-19-037565-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919119037570/0001209191-19-037570-index.htm
2019-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919119045483/0001209191-19-045483-index.htm
2019-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919119046444/0001209191-19-046444-index.htm
2019-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919119046445/0001209191-19-046445-index.htm
2019-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919119046446/0001209191-19-046446-index.htm
2019-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919119051012/0001209191-19-051012-index.htm
2019-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919119051016/0001209191-19-051016-index.htm
2019-10-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919119052907/0001209191-19-052907-index.htm
2019-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919119059461/0001209191-19-059461-index.htm
2019-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919119059463/0001209191-19-059463-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919120006189/0001209191-20-006189-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919120010479/0001209191-20-010479-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919120010481/0001209191-20-010481-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919120010484/0001209191-20-010484-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919120010487/0001209191-20-010487-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919120010527/0001209191-20-010527-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919120018736/0001209191-20-018736-index.htm
2020-03-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919120019083/0001209191-20-019083-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919120036333/0001209191-20-036333-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919120036340/0001209191-20-036340-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919120036344/0001209191-20-036344-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919120036346/0001209191-20-036346-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919120036348/0001209191-20-036348-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919120036350/0001209191-20-036350-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919120036352/0001209191-20-036352-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919120038683/0001209191-20-038683-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919120047575/0001209191-20-047575-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919120047577/0001209191-20-047577-index.htm
2020-09-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1367920/000120919120048893/0001209191-20-048893-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1367920/000125889720000885/0001258897-20-000885-index.htm
2018-05-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1367920/000136792018000022/0001367920-18-000022-index.htm
2018-05-0310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1367920/000136792018000023/0001367920-18-000023-index.htm
2018-05-03DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1367920/000136792018000024/0001367920-18-000024-index.htm
2018-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1367920/000136792018000026/0001367920-18-000026-index.htm
2018-08-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1367920/000136792018000031/0001367920-18-000031-index.htm
2018-08-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1367920/000136792018000032/0001367920-18-000032-index.htm
2018-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1367920/000136792018000036/0001367920-18-000036-index.htm
2018-11-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1367920/000136792018000037/0001367920-18-000037-index.htm
2018-12-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1367920/000136792018000039/0001367920-18-000039-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1367920/000136792019000007/0001367920-19-000007-index.htm
2019-02-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1367920/000136792019000009/0001367920-19-000009-index.htm
2019-02-28S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1367920/000136792019000010/0001367920-19-000010-index.htm
2019-03-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1367920/000136792019000019/0001367920-19-000019-index.htm
2019-03-01424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1367920/000136792019000020/0001367920-19-000020-index.htm
2019-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1367920/000136792019000022/0001367920-19-000022-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1367920/000136792019000031/0001367920-19-000031-index.htm
2019-05-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1367920/000136792019000032/0001367920-19-000032-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1367920/000136792019000033/0001367920-19-000033-index.htm
2019-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1367920/000136792019000035/0001367920-19-000035-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1367920/000136792019000041/0001367920-19-000041-index.htm
2019-08-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1367920/000136792019000042/0001367920-19-000042-index.htm
2019-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1367920/000136792019000046/0001367920-19-000046-index.htm
2019-10-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1367920/000136792019000051/0001367920-19-000051-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1367920/000136792019000056/0001367920-19-000056-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1367920/000136792019000057/0001367920-19-000057-index.htm
2020-01-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1367920/000136792020000003/0001367920-20-000003-index.htm
2020-01-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1367920/000136792020000005/0001367920-20-000005-index.htm
2020-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1367920/000136792020000012/0001367920-20-000012-index.htm
2020-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1367920/000136792020000013/0001367920-20-000013-index.htm
2020-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1367920/000136792020000014/0001367920-20-000014-index.htm
2020-04-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1367920/000136792020000019/0001367920-20-000019-index.htm
2020-04-28DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1367920/000136792020000020/0001367920-20-000020-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1367920/000136792020000021/0001367920-20-000021-index.htm
2020-04-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1367920/000136792020000022/0001367920-20-000022-index.htm
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1367920/000136792020000028/0001367920-20-000028-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1367920/000136792020000037/0001367920-20-000037-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1367920/000136792020000039/0001367920-20-000039-index.htm
2020-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1367920/000136792020000044/0001367920-20-000044-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1367920/000136792020000053/0001367920-20-000053-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1367920/000136792020000055/0001367920-20-000055-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1367920/000138713120001846/0001387131-20-001846-index.htm
2019-03-25SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1367920/000149315219003826/0001493152-19-003826-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1367920/000149315220002377/0001493152-20-002377-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1367920/000156761920003793/0001567619-20-003793-index.htm

Concert Pharmaceuticals, Inc (CNCE) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Concert Pharmaceuticals, Inc (CNCE). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1025%
Institutional Ownership: 7092%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-10-08Heek Christi vanDirectorBuy5,000.005.9029,503.5010,000.00https://www.sec.gov/Archives/edgar/data/1367920/000120919119052907/0001209191-19-052907-index.htm
2019-12-04Nancy StuartChief Operating OfficerBuy5,896.004.4126,001.36104,739.00https://www.sec.gov/Archives/edgar/data/1367920/000120919119059463/0001209191-19-059463-index.htm
2018-07-09Nancy StuartChief Operating OfficerSell5,291.0017.5692,889.85116,085.00https://www.sec.gov/Archives/edgar/data/1367920/000120919118042304/0001209191-18-042304-index.htm
2019-02-06Nancy StuartChief Operating OfficerBuy28,616.004.41126,196.56116,724.00https://www.sec.gov/Archives/edgar/data/1367920/000120919119008083/0001209191-19-008083-index.htm
2019-06-10PARTNERS L P/IL BVF10% Share HolderSell198,256.0010.702,122,112.401,178,904.00https://www.sec.gov/Archives/edgar/data/1367920/000092189519001804/0000921895-19-001804-index.htm
2020-02-14Nancy StuartChief Operating OfficerBuy45,363.00146,686.00https://www.sec.gov/Archives/edgar/data/1367920/000120919120010484/0001209191-20-010484-index.htm
2020-06-22Nancy StuartChief Operating OfficerSell10,295.0011.34116,693.83157,629.00https://www.sec.gov/Archives/edgar/data/1367920/000120919120038683/0001209191-20-038683-index.htm
2020-06-22Nancy StuartChief Operating OfficerBuy21,238.003.7980,492.02167,924.00https://www.sec.gov/Archives/edgar/data/1367920/000120919120038683/0001209191-20-038683-index.htm
2019-06-10PARTNERS L P/IL BVF10% Share HolderSell29,450.0010.70315,229.86169,589.00https://www.sec.gov/Archives/edgar/data/1367920/000092189519001804/0000921895-19-001804-index.htm
2019-08-15Ryan LynchPAOBuy14,063.0018,059.00https://www.sec.gov/Archives/edgar/data/1367920/000120919119046446/0001209191-19-046446-index.htm
2019-08-15Marc A. BeckerCFO, PFOBuy28,093.0028,093.00https://www.sec.gov/Archives/edgar/data/1367920/000120919119046445/0001209191-19-046445-index.htm
2020-02-14Jeffrey A MunsieChief Legal OfficerBuy28,216.0028,216.00https://www.sec.gov/Archives/edgar/data/1367920/000120919120010527/0001209191-20-010527-index.htm
2018-11-15RICHARD ALDRICHDirectorBuy10,000.0012.00119,994.00296,975.00https://www.sec.gov/Archives/edgar/data/1367920/000120919118058781/0001209191-18-058781-index.htm
2018-11-14Auchincloss Thomas GDirectorBuy1,000.0011.9311,931.403,000.00https://www.sec.gov/Archives/edgar/data/1367920/000120919118058782/0001209191-18-058782-index.htm
2018-04-17James V CassellaChief Development OfficerSell10,582.0020.18213,509.8430,000.00https://www.sec.gov/Archives/edgar/data/1367920/000120919118025549/0001209191-18-025549-index.htm
2018-11-15RICHARD ALDRICHDirectorBuy40,000.0011.78471,268.00336,975.00https://www.sec.gov/Archives/edgar/data/1367920/000120919118058781/0001209191-18-058781-index.htm
2018-11-15Auchincloss Thomas GDirectorBuy1,000.0011.5011,500.004,000.00https://www.sec.gov/Archives/edgar/data/1367920/000120919118059254/0001209191-18-059254-index.htm
2019-08-08PETER BARTON HUTTDirectorSell3,539.0010.3136,487.094,424.00https://www.sec.gov/Archives/edgar/data/1367920/000120919119045483/0001209191-19-045483-index.htm
2020-02-03Auchincloss Thomas GDirectorBuy1,000.0010.9110,910.005,000.00https://www.sec.gov/Archives/edgar/data/1367920/000120919120006189/0001209191-20-006189-index.htm
2019-08-02Heek Christi vanDirectorBuy5,000.0010.8454,203.005,000.00https://www.sec.gov/Archives/edgar/data/1367920/000120919119052907/0001209191-19-052907-index.htm
2019-08-15James V CassellaChief Development OfficerBuy31,100.0052,265.00https://www.sec.gov/Archives/edgar/data/1367920/000120919119046444/0001209191-19-046444-index.htm
2020-08-17Marc A. BeckerChief Financial OfficerSell2,875.0010.2429,440.0053,434.00https://www.sec.gov/Archives/edgar/data/1367920/000120919120047575/0001209191-20-047575-index.htm
2020-02-14Marc A. BeckerChief Financial OfficerBuy28,216.0056,309.00https://www.sec.gov/Archives/edgar/data/1367920/000120919120010479/0001209191-20-010479-index.htm
2019-04-10Roger D TungChief Executive OfficerBuy24,886.004.41109,747.26616,919.00https://www.sec.gov/Archives/edgar/data/1367920/000120919119024246/0001209191-19-024246-index.htm
2019-04-23Roger D TungChief Executive OfficerBuy14,601.003.7955,337.79631,520.00https://www.sec.gov/Archives/edgar/data/1367920/000120919119025761/0001209191-19-025761-index.htm
2019-12-04Roger D TungChief Executive OfficerBuy13,166.004.4158,062.06644,686.00https://www.sec.gov/Archives/edgar/data/1367920/000120919119059461/0001209191-19-059461-index.htm
2020-03-12Auchincloss Thomas GDirectorBuy1,500.008.5212,772.506,500.00https://www.sec.gov/Archives/edgar/data/1367920/000120919120018736/0001209191-20-018736-index.htm
2020-02-14Roger D TungChief Executive OfficerBuy101,100.00738,157.00https://www.sec.gov/Archives/edgar/data/1367920/000120919120010487/0001209191-20-010487-index.htm
2020-03-13Roger D TungChief Executive OfficerBuy14,601.003.7955,337.79752,758.00https://www.sec.gov/Archives/edgar/data/1367920/000120919120019083/0001209191-20-019083-index.htm
2020-08-17James V CassellaChief Development OfficerSell4,354.0010.3745,150.9876,127.00https://www.sec.gov/Archives/edgar/data/1367920/000120919120047577/0001209191-20-047577-index.htm
2019-08-08PETER BARTON HUTTDirectorBuy3,539.004.4115,606.997,963.00https://www.sec.gov/Archives/edgar/data/1367920/000120919119045483/0001209191-19-045483-index.htm
2020-08-31PETER BARTON HUTTDirectorBuy3,539.003.7913,412.817,963.00https://www.sec.gov/Archives/edgar/data/1367920/000120919120048893/0001209191-20-048893-index.htm
2020-02-14James V CassellaChief Development OfficerBuy28,216.0080,481.00https://www.sec.gov/Archives/edgar/data/1367920/000120919120010481/0001209191-20-010481-index.htm
2018-07-10Nancy StuartChief Operating OfficerSell26,127.0017.94468,697.4889,958.00https://www.sec.gov/Archives/edgar/data/1367920/000120919118042304/0001209191-18-042304-index.htm
2019-06-10PARTNERS L P/IL BVF10% Share HolderSell158,583.0010.701,697,456.57952,859.00https://www.sec.gov/Archives/edgar/data/1367920/000092189519001804/0000921895-19-001804-index.htm